MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis | Zendy

Yisha Li | Zendy; Jing Huang | Zendy; Muyao Guo | Zendy; Xiaoxia Zuo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis

Author(s) -

Yisha Li,

Jing Huang,

Muyao Guo,

Xiaoxia Zuo

Publication year - 2015

Publication title -

genomics proteomics and bioinformatics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.114

H-Index - 49

eISSN - 2210-3244

pISSN - 1672-0229

DOI - 10.1016/j.gpb.2015.07.001

Subject(s) - microrna , signal transduction , computational biology , biological pathway , biology , pathway analysis , microbiology and biotechnology , bioinformatics , gene , genetics , gene expression

Systemic sclerosis (SSc) is a multisystem fibrotic and autoimmune disease. Both genetic and epigenetic elements mediate SSc pathophysiology. This review summarizes the role of one epigenetic element, known as microRNAs (miRNAs), involved in different signaling pathways of SSc pathogenesis. The expression of key components in transforming growth factor-β (TGF-β) signaling pathway has been found to be regulated by miRNAs both upstream and downstream of TGF-β. We are specifically interested in the pathway components upstream of TGF-β, while miRNAs in other signaling pathways have not been extensively studied. The emerging role of miRNAs in vasculopathy of SSc suggests a promising new direction for future investigation. Elucidation of the regulatory role of miRNAs in the expression of signaling factors may facilitate the discovery of novel biomarkers in SSc and improve the understanding and treatment of this disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research